Skip Ribbon Commands
Skip to main content
Sign In

25057 Tick Borne Panel (Does not include Lyme disease testing at this time)

Tick Borne Panel (Does not include Lyme disease testing at this time)
Test Code: TICKP
Synonyms/Keywords
​Anaplasma phagocytophilum, Babesia microti, Babesiosis, Ehrlichia/Anaplasma
Test Components

​ANENAT -Anaplasma phagocytophilum,  Ehrlichia species

BABNAT - Babesia microti

Useful For

- Evaluation of the most common tick-borne diseases found in the United States, including anaplasmosis,    ehrlichiosis, and babesiosis.
- Does not include Lyme disease testing at this time.  Order LYMPAN for Lyme disease serology on serum.
- Evaluation of patients with a history of, or suspected, tick exposure who are presenting with fever, myalgia, headache, nausea, and other nonspecific symptoms.

This panel consists of two Real-Time PCR tests. Anaplasma/Ehrlichia (ANENAT) test and detection of Babesia microti (BABNAT).This panel should not be used for screening asymptomatic individuals, and should only be used to test patients with signs and symptoms of Ehrlichiosis/Anaplasmosis and/or Babesiosis.
Specimen Requirements
Fasting Required Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
​No ​Whole Blood EDTA Lavender Top Tube (LTT)​ 3.0 mL​ 1.2 mL 0.6 mL
Collection Processing Instructions
Draw a separate tube for this test. Sample cannot be entered for another test under conditions where cross contamination may occur.​
Specimen Stability Information
Specimen Type Temperature Time​
​Whole Blood EDTA ​ ​Refrigerate 7 days​
Rejection Criteria
Anticoagulants other than EDTA
​Gross Lipemia
Performing Laboratory Information
Performing Location Day(s) Test Performed Analytical Time Methodology/Instrumentation

​Marshfield

Monday through Friday​
6-8 hours*
Polymerase Chain Reaction, PCR
*Testing performed once/day.
Sample must be received in the lab by 0400 to be tested same day. ​ ​ ​ ​
Test Information

This test was developed and its performance characteristics determined by Marshfield Labs.  It has not been cleared or approved by the U.S. Food and Drug Administration.  The FDA has determined that such clearance or approval is not necessary.  This test is for clinical purposes.  It should not be regarded as investigational or for research.  This laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high complexity clinical testing.

Reference Range Information
Performing Location Reference Range
​Marshfield
Negative for Babesia microti
Negative for Anaplasma phagocytophilum and Ehrlichia species
Outreach CPTs
CPT Modifier
(if needed)
Quantity Description Comments
​87798 3​
Classification

This test was developed and its performance characteristics determined by Marshfield Labs.  It has not been cleared or approved by the U.S. Food and Drug Administration.  The FDA has determined that such clearance or approval is not necessary.  This test is for clinical purposes.  It should not be regarded as investigational or for research.  This laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high complexity clinical testing.

Synonyms/Keywords
​Anaplasma phagocytophilum, Babesia microti, Babesiosis, Ehrlichia/Anaplasma
Test Components

​ANENAT -Anaplasma phagocytophilum,  Ehrlichia species

BABNAT - Babesia microti

Ordering Applications
Ordering Application Description
​Centricity ​Tick Borne Panel
​Cerner ​Tick Borne Panel
If the ordering application you are looking for is not listed, contact your local laboratory for assistance.
Specimen Requirements
Fasting Required Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
​No ​Whole Blood EDTA Lavender Top Tube (LTT)​ 3.0 mL​ 1.2 mL 0.6 mL
Collection Processing
Draw a separate tube for this test. Sample cannot be entered for another test under conditions where cross contamination may occur.​
Specimen Stability Information
Specimen Type Temperature Time​
​Whole Blood EDTA ​ ​Refrigerate 7 days​
Rejection Criteria
Anticoagulants other than EDTA
​Gross Lipemia
Useful For

- Evaluation of the most common tick-borne diseases found in the United States, including anaplasmosis,    ehrlichiosis, and babesiosis.
- Does not include Lyme disease testing at this time.  Order LYMPAN for Lyme disease serology on serum.
- Evaluation of patients with a history of, or suspected, tick exposure who are presenting with fever, myalgia, headache, nausea, and other nonspecific symptoms.

This panel consists of two Real-Time PCR tests. Anaplasma/Ehrlichia (ANENAT) test and detection of Babesia microti (BABNAT).This panel should not be used for screening asymptomatic individuals, and should only be used to test patients with signs and symptoms of Ehrlichiosis/Anaplasmosis and/or Babesiosis.
Test Components

​ANENAT -Anaplasma phagocytophilum,  Ehrlichia species

BABNAT - Babesia microti

Reference Range Information
Performing Location Reference Range
​Marshfield
Negative for Babesia microti
Negative for Anaplasma phagocytophilum and Ehrlichia species
For more information visit:
Performing Laboratory Information
Performing Location Day(s) Test Performed Analytical Time Methodology/Instrumentation

​Marshfield

Monday through Friday​
6-8 hours*
Polymerase Chain Reaction, PCR
*Testing performed once/day.
Sample must be received in the lab by 0400 to be tested same day. ​ ​ ​ ​
For billing questions, see Contacts
Outreach CPTs
CPT Modifier
(if needed)
Quantity Description Comments
​87798 3​
Classification

This test was developed and its performance characteristics determined by Marshfield Labs.  It has not been cleared or approved by the U.S. Food and Drug Administration.  The FDA has determined that such clearance or approval is not necessary.  This test is for clinical purposes.  It should not be regarded as investigational or for research.  This laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high complexity clinical testing.

For most current information refer to the Marshfield Laboratory online reference manual.